XAIR

Q: What is the price of Beyond Air (XAIR) today?

The current price of Beyond Air (XAIR) is $5.98. The stock began the year trading around $0.73 and is currently priced at $5.98. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Beyond Air (XAIR) pay dividends?

Beyond Air (XAIR) did not pay dividends over the past year.

Q: Is Beyond Air (XAIR) a good investment?

Beyond Air (XAIR) is currently trading at $5.98 with a P/E ratio of -0.17. This represents a -3% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -90.83%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Beyond Air Inc.

Price

$5.98

return (12m)

-90.83%

p/e

-0.17

p/bv

0.89

DIVIDEND YIELD

0.00%

XAIR price

Beyond Air

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment XAIR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-16.94%

3 months

-41.98%

1 year

-90.83%

2 years

-97.37%

5 years

-99.82%

10 years

0.00%

Fundamentals XAIR

review the fundamentals of Beyond Air shares

P/E

-0.17

Sector: -2.36 Industry: 0.98

P/Revenue (PSR)

0.72

Sector: 2.00 Industry: 0.76

P/BV

0.89

Sector: 2.16 Industry: 2.53

Dividend Yield (DY)

0.00%

Sector: - Industry: -

Payout

Sector: - Industry: -

Net Profit Margins

-100.00%

Sector: -30.34% Industry: -16.97%

Gross Margin

3.26%

Sector: 44.07% Industry: 30.88%

Operating Margin

-100.00%

Sector: -25.88% Industry: -7.64%

EBIT Margin

-478.01%

Sector: - Industry: -

EBITDA Margin

-429.84%

Sector: - Industry: -

EV/EBITDA

-1.89

Sector: - Industry: -

EV/EBIT

-1.70

Sector: - Industry: -

P/EBITDA

-0.20

Sector: -0.13 Industry: 1.08

P/EBIT

-0.18

Sector: -2.10 Industry: 3.17

P/Total Assets

0.16

Sector: 1.17 Industry: 0.93

P/Working Capital

0.30

Sector: - Industry: -

P/Net Current Assets

-1.25

Sector: - Industry: -

BVPS

6.21

Sector: 3.88 Industry: 5.17

EPS

-33.25

Sector: -0.93 Industry: -0.57

Asset Turnover

0.05

Sector: - Industry: -

ROE

-535.43%

Sector: -34.57% Industry: -29.67%

ROIC

-139.55%

Sector: -441.27% Industry: -111.79%

ROA

-93.98%

Sector: -28.64% Industry: -15.42%

Net Debt / Equity

1.61

Sector: - Industry: -

Net Debt / EBITDA

-1.22

Sector: - Industry: -

Net Debt / EBIT

-1.10

Sector: - Industry: -

Gross Debt / Equity

3.48

Sector: - Industry: -

Equity / Assets

0.18

Sector: 0.43 Industry: 0.26

Liabilities / Assets

0.82

Sector: 0.46 Industry: 0.48

Current Ratio

3.80

Sector: - Industry: -

CAGR Revenue 5 Years

122.76%

Sector: - Industry: -

CAGR Profit 5 Years

3.20%

Sector: - Industry: -

Fundamentals XAIR

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
XAIR	-0.17	0.89	-535.43%	0.00%	$5.50 M	-100.00%
LLY	41.74	33.82	81.02%	0.55%	$1.06 T	34.99%
ISRG	39.67	6.81	17.15%	0.00%	$124.53 B	28.45%
SNY	7.21	1.28	17.79%	4.00%	$107.73 B	14.75%
NVS	21.74	7.56	34.77%	2.01%	$294.21 B	23.92%
TMO	29.07	3.82	13.15%	0.34%	$199.09 B	15.15%
ABT	25.64	3.09	12.06%	0.00%	$160.92 B	13.91%
MDT	22.18	2.13	9.59%	3.43%	$106.50 B	13.20%
GSK	13.20	4.46	33.77%	3.41%	$103.53 B	17.79%
CVS	46.88	1.77	3.78%	2.46%	$137.46 B	0.72%
BSX	18.45	2.54	13.78%	0.00%	$65.78 B	17.29%
IDXX	41.21	29.00	70.38%	0.00%	$45.13 B	24.63%
TMDX	14.70	5.12	34.80%	0.00%	$2.53 B	27.04%
RMD	19.01	4.45	23.41%	1.20%	$28.89 B	27.44%
HCA	12.41	-28.31	-228.14%	0.80%	$84.32 B	8.89%
DHR	38.96	2.71	6.97%	0.67%	$143.74 B	14.89%
SYK	36.85	5.35	14.52%	1.07%	$122.99 B	13.21%
PHG	22.75	1.95	8.56%	3.75%	$25.71 B	5.50%
COHR	114.66	4.88	4.26%	0.00%	$53.76 B	7.10%
INMD	11.26	1.48	13.18%	0.00%	$981.23 M	23.27%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

XAIR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Beyond Air

Beyond Air Inc.

Average Investor10 user rating

4.0 (1 people)

United States

11 years

Founded: 2015

2016

Time since IPO - 10 years

23

Employees

Beyond Air Inc. (United States) is listed on the Nasdaq and has a market capitalization of $5.50 million, with shareholders equity totaling $6.21 million.

The company employs approximately 23 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Beyond Air Inc. reported $7.68 million in revenue, generating net income of $-33.25 million.

Key financial metrics include a P/E ratio of -0.17, a price-to-book (P/B) ratio of 0.89, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker XAIR.

Market cap

$5.50 million

Net worth

$6.21 million

$6,210,000.00

Assets

$35.38 million

$35,380,000.00

Total Shares Outstanding

1.00 million

1,000,000

Average Daily Trading Volume

$16.51 Thousand

$16,510.63

Sector

Health

Industry

Medical Supplies and Equipment

XAIR

XAIR revenue and profits

Financial Results XAIR

DRAG THE FRAME TO SEE MORE DATA

XAIR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$107.61 82,06% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$283.94 --1,56% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$65.83 139,99% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$398.20 81,47% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$43.98 --4,62% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$1,146.90 48,98% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$370.42 2,28% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$149.56 33,58% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56